Izumi, Chisato https://orcid.org/0000-0002-3282-1327
Amano, Masashi
Fukushima, Satsuki
Yaku, Hitoshi
Eishi, Kiyoyuki
Sakaguchi, Taichi
Minami, Manabu
Yamamoto, Haruko
Onda, Kaori
Omae, Katsuhiro
Funding for this research was provided by:
Daiichi Sankyo Company
Article History
Accepted: 21 May 2024
First Online: 24 June 2024
Declarations
:
: Dr Izumi has received speaker honoraria from Daiichi Sankyo Co., Ltd, Nippon Boehringer Ingelheim and Novartis and research funding from Pfizer, LSI Medience Co, PPD-SNBL K.K, Abott Medical Japan, Bristol-Myers Squibb, and Eli Lilly and Company.The other authors have no relevant financial or non-financial interests to disclose.
: Daiichi Sankyo Co., Ltd. and the National Cerebral and Cardiovascular Center had entered into a research agreement before the study started. Daiichi Sankyo Co., Ltd. is not involved in the design, management, analysis, and reporting of the study.
: Not applicable.